Impact of lung adenocarcinoma subtypes on survival and timing of brain metastases
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Lung adenocarcinoma with brain metastases shows poorer prognosis in poorly differentiated subtypes. Early treatment interventions like radiation, chemotherapy, and surgery improve outcomes for these patients.
Area Of Science
- Oncology
- Medical Research
Background
- Lung adenocarcinoma frequently metastasizes to the brain.
- Understanding prognostic factors is crucial for managing brain metastases.
Purpose Of The Study
- Investigate prognostic characteristics of lung adenocarcinoma brain metastases based on pathological subtypes.
- Provide a reference for patient management.
Main Methods
- Collected clinical data from 156 patients.
- Classified patients by pathological subtype (highly vs. poorly differentiated).
- Utilized propensity score matching, Kaplan-Meier analysis, and Cox regression.
Main Results
- Moderately to highly differentiated subtypes showed better prognoses.
- Poorly differentiated subtypes were a risk factor for poorer prognosis.
- Radiation, chemotherapy, and surgery improved the interval to brain metastasis.
Conclusions
- Pathological subtypes significantly impact prognosis in lung adenocarcinoma brain metastases.
- Poorly differentiated subtypes warrant closer monitoring and aggressive treatment.
- Treatment interventions positively influence patient outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
